Trevena Now Covered by Jefferies Group (TRVN)
Investment analysts at Jefferies Group started coverage on shares of Trevena (NASDAQ:TRVN) in a note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $11.00 price target on the stock. Jefferies Group’s price target indicates a potential upside of 41.57% from the stock’s previous close.
Trevena, Inc (NASDAQ:TRVN) is a clinical stage biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.